2022-503047-17-00已完成1 期
A study in healthy men to test how BI 1810631 is taken up and processed by the body.
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 15
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
CT Disclosure & Data Transparency
Scientific
Boehringer Ingelheim International GmbH
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A study in healthy men to test how BI 1569912 is processed in the body2023-510464-12-00Boehringer Ingelheim International GmbH8
已完成
不适用
A study in healthy men to test how BI 474121 is toleratedjRCT2071210040Boehringer Ingelheim32
已完成
1 期
A study in healthy men to test how BI 764198 is processed in the body2022-502327-22-00Boehringer Ingelheim International GmbH16
已完成
1 期
A study in healthy people to test how BI 1015550 is taken up in the body when given with or without food2023-509889-38-00Boehringer Ingelheim International GmbH18
已完成
1 期
A phase I study to determine the tolerability and safety of transdermally delivered oxycodone in combination with the novel penetration enhancer tocopheryl phosphate mix (TPM).To promote pain relief in healthy volunteers.Anaesthesiology - Pain managementACTRN12609000836235Phosphagenics Limited44